Breaking News Instant updates and real-time market news.

IBM

IBM

$169.12

0.47 (0.28%)

18:19
01/18/18
01/18
18:19
01/18/18
18:19

IBM's Schroeter says mainframe isn't going away

IBM senior VP of Global Markets Martin Schroeter said in an interview on CNBC's "Mad Money" that the company's mainframe isn't going away and that it's still the most robust platform. Schroeter added that the company finished "really well" in terms of cash in the fourth quarter, and that the company is experiencing some tax headwinds with earnings per share.

  • 18

    Jan

IBM IBM
$169.12

0.47 (0.28%)

01/12/18
BMOC
01/12/18
NO CHANGE
Target $175
BMOC
Market Perform
IBM price target raised to $175 from $170 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on IBM to $175, reiterating that the mainframe cycle and FX trends are beginning to improve. The analyst keeps his Market Perform rating based on valuations, but suggests that the December quarter estimates could prove to be conservative. Longer term, Bachman contends that the Systems segment could generate "durable growth" and the Cognitive business can grow operating profits this year.
01/17/18
LEHM
01/17/18
UPGRADE
Target $192
LEHM
Overweight
IBM upgraded to Overweight from Underweight at Barclays
Barclays analyst Mark Moskowitz double upgraded IBM (IBM) to Overweight from Underweight and raised his price target for the shares to $192 from $133. The technology giant closed yesterday up 69c to $163.85. The company could be entering a period of top-line stability and maybe even modest growth over the next 12-18 months, Moskowitz tells investors in a research note. The analyst thinks IBM could emerge over time as the next important cloud vendor after Amazon (AMZN) and Microsoft's (MSFT) Azure. Moskowitz sees room for another cloud player and thinks the "narrative can favorably shift for shares of IBM."
01/17/18
01/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IBM (IBM) upgraded to Overweight from Underweight at Barclays with analyst Mark Moskowitz saying the company could be entering a period of top-line stability and maybe even modest growth over the next 12-18 months. 2. Ulta Beauty (ULTA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying Ulta shares are trading at a compelling multiple given the company's long runway for earnings per share growth combined with benefits from lower tax rates. 3. Groupon (GRPN) upgraded to Neutral from Sell at Goldman Sachs with analyst Christopher Merwin saying stabilizing gross profit growth, coupled with cost savings, should drive upside to Street EBITDA expectations in 2018. 4. L3 Technologies (LLL) upgraded to Buy from Neutral at BofA/Merrill with analyst Ronald Epstein saying it will benefit from "upward momentum" in the U.S. defense budget. 5. Dick's Sporting (DKS) upgraded to Buy from Neutral at Buckingham with the firm citing tax reform benefits and recent strength across retail. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
WEDB
01/18/18
NO CHANGE
Target $185
WEDB
Neutral
IBM price target raised to $185 from $155 at Wedbush
Wedbush analyst Moshe Katri raised his price target for IBM to $185 from $155 on valuation. The analyst reiterates a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

CACI

CACI

$179.00

0.9 (0.51%)

08:09
07/18/18
07/18
08:09
07/18/18
08:09
Hot Stocks
CACI awarded task order with $122M ceiling by GSA »

CACI announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.11

0.21 (0.70%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Hot Stocks
Genpact to acquire Barkawi Management Consultants, terms not disclosed »

Genpact has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 07

    Aug

EXAS

Exact Sciences

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Recommendations
Exact Sciences analyst commentary  »

Exact Sciences price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 26

    Jul

  • 01

    Aug

  • 02

    Aug

NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

, EDIT

Editas Medicine

$36.46

1.31 (3.73%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Recommendations
Intellia Therapeutics, Editas Medicine, Crispr Therapeutics analyst commentary  »

Study in Nature Biotech…

NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

EDIT

Editas Medicine

$36.46

1.31 (3.73%)

CRSP

Crispr Therapeutics

$61.98

1.95 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

$42.54

-0.28 (-0.65%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Downgrade
American Campus rating change  »

American Campus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BA

Boeing

$356.95

0.94 (0.26%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Hot Stocks
Boeing subsidiary granted maintenance contract by Romanian Air Force »

Boeing subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PERY

Perry Ellis

$28.32

0.06 (0.21%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Hot Stocks
Perry Ellis special committee reiterates commitment to Feldenkreis transaction »

The special committee of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATOS

Atossa Genetics

$2.47

-0.1 (-3.89%)

08:06
07/18/18
07/18
08:06
07/18/18
08:06
Hot Stocks
Atossa Genetics announces intraductal microcatheter immunotherapy program »

Atossa Genetics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$130.45

-0.34 (-0.26%)

08:06
07/18/18
07/18
08:06
07/18/18
08:06
Hot Stocks
Marriott removing plastic straws worldwide by July 2019 »

Marriott has adopted a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

NVEE

NV5 Global

$72.85

0.85 (1.18%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Hot Stocks
NV5 Global announces additional commissioning task order for U.S. Embassy »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

GTT

GTT Communications

$46.55

0.1 (0.22%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Hot Stocks
GTT Communications awarded three-year contract valued at $24M by DITCO »

GTT Communications has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAFD

Washington Federal

$32.90

-0.25 (-0.75%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Earnings
Washington Federal reports Q2 EPS 61c, consensus 59c »

Return on equity for Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

GWW

Grainger

$305.21

2.22 (0.73%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Hot Stocks
Grainger CEO says 'The second quarter exceeded our expectations' »

"The second quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TWTR

Twitter

$44.70

0.45 (1.02%)

08:04
07/18/18
07/18
08:04
07/18/18
08:04
Hot Stocks
Bloomberg announces launch of Twitter feed optimized for trading »

Bloomberg announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FMNB

Farmers National Banc

$16.20

-0.2 (-1.22%)

08:04
07/18/18
07/18
08:04
07/18/18
08:04
Earnings
Farmers National Banc reports Q2 EPS 29c, consensus 28c »

Annualized return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDWR

Radware

$27.03

-0.23 (-0.84%)

08:04
07/18/18
07/18
08:04
07/18/18
08:04
Recommendations
Radware analyst commentary  »

Jefferies boosts target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

GWW

Grainger

$305.21

2.22 (0.73%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Earnings
Grainger raises FY18 EPS view to 15.05-$16.05 from $14.30-$15.30 »

FY18 consensus $15.01.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TRCO

Tribune Media

$33.30

1.25 (3.90%)

, SBGI

Sinclair Broadcast

$28.00

-1.1 (-3.78%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Recommendations
Tribune Media, Sinclair Broadcast analyst commentary  »

Tribune Media price…

TRCO

Tribune Media

$33.30

1.25 (3.90%)

SBGI

Sinclair Broadcast

$28.00

-1.1 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

CLNY

Colony Capital

$5.97

-0.11 (-1.81%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Hot Stocks
Colony Industrial acquires Yellow Brick Road portfolio in Baltimore »

Colony Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

IMMU

Immunomedics

$25.40

-0.09 (-0.35%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Hot Stocks
Immunomedics: FDA accepts BLA, grants priority review for sacituzumab govitecan »

Immunomedics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTI

Ultimate Software

$284.44

2.44 (0.87%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Recommendations
Ultimate Software analyst commentary  »

Ultimate Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 31

    Jul

CATS

Catasys

$6.73

-0.015 (-0.22%)

, GE

General Electric

$13.70

-0.2 (-1.44%)

08:02
07/18/18
07/18
08:02
07/18/18
08:02
Hot Stocks
Catasys names Jeremiah Stone as Chief Technology Officer »

Catasys (CATS) announced…

CATS

Catasys

$6.73

-0.015 (-0.22%)

GE

General Electric

$13.70

-0.2 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$64.42

0.46 (0.72%)

08:02
07/18/18
07/18
08:02
07/18/18
08:02
Recommendations
CSX analyst commentary  »

CSX shares deserve to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

CLRB

Cellectar Biosciences

$7.38

-0.027 (-0.36%)

08:01
07/18/18
07/18
08:01
07/18/18
08:01
Hot Stocks
Cellectar Biosciences reports 'positive' Phase 2 interim data for CLR 131 »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$28.00

-1.1 (-3.78%)

, TRCO

Tribune Media

$33.30

1.25 (3.90%)

08:01
07/18/18
07/18
08:01
07/18/18
08:01
Recommendations
Sinclair Broadcast, Tribune Media analyst commentary  »

Sinclair Broadcast price…

SBGI

Sinclair Broadcast

$28.00

-1.1 (-3.78%)

TRCO

Tribune Media

$33.30

1.25 (3.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.